Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) General Information
Description
Manufacturer and seller of bio pharmaceutical products. The company is engaged in researching, developing and manufacturing drugs, medical supplies and other medical equipment.
Contact Information
Corporate Office
- 1405 Research Boulevard
- Rockville, MD 20850
- United States
Corporate Office
- 1405 Research Boulevard
- Rockville, MD 20850
- United States
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) FAQs
-
Where is Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) headquartered?
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) is headquartered in Rockville, MD.
-
What industry is Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) in?
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)’s primary industry is Drug Discovery.
-
Is Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) a private or public company?
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) is a Private company.
-
What is Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)’s current revenue?
The current revenue for Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) is .
-
Who are Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)’s investors?
Aeras Global TB Vaccine Foundation has invested in Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center).
-
When was Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) acquired?
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) was acquired on 23-Jun-2015.
-
Who acquired Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)?
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) was acquired by IDT Biologika.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process